It has only been tried in mice thus far, yet the drug shows promise at treating a real problem of socialization.
Low doses of a compound called romidepsin might help those on the autism spectrum overcome the social challenges that define their condition.
So far it has only been shown to be effective in mice, but the mechanisms behind the drug’s activity make it a promising candidate for an autism treatment in humans – the first of its kind.
Autism spectrum disorder (ASD) is an umbrella term for traits that interfere with the brain’s ability to process stimuli and negotiate social cues, often making communication difficult.
Of course mice aren’t people, but since the mechanisms appear to be the same, there’s hope that the drug’s effects will be as well.
The fact it’s already FDA approved also suggests a treatment is tantalizingly on the horizon.
It’s important to keep in mind that there’s still plenty of research between this study and a publicly available treatment.